Last updated on April 19, 2014 at 17:21 EDT

Latest Radboud University Nijmegen Medical Centre Stories

2012-10-15 07:28:09

NIJMEGEN, Netherlands, Oct. 15, 2012 /PRNewswire/ - The first of three newly acquired Elekta Synergy® treatment systems equipped with Agility(TM)* 160-leaf multi-leaf collimator (MLC) is now up and running clinically at Radboud University Nijmegen Medical Center - making the clinic the first in the Netherlands to use Agility. The first patient, a 48-year-old woman, was treated on September 10 and clinicians have treated 70 additional patients since then, encompassing a wide...

2009-04-22 08:00:00

BILTHOVEN and NIJMEGEN, The Netherlands, April 22 /PRNewswire/ -- InteRNA Technologies B.V. and Radboud University Nijmegen Medical Centre have entered into a research agreement to develop microRNA (miRNA)-based therapeutics for prostate cancer. Under the research collaboration with professor Jack Schalken (Laboratory of Experimental Urology), InteRNA's unique lentiviral-based miRNA overexpression library will be applied in multi-parametric, high-throughput functional screening...